UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

Annals of oncology, 2004-03, Vol.15 (3), p.526-536

2004

Volltextzugriff (PDF)

Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months

Journal of the European Academy of Dermatology and Venereology, 2010-09, Vol.24 (9), p.1040-1046

2010

Volltextzugriff (PDF)

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study

The European respiratory journal, 2003-01, Vol.21 (1), p.116-122

2003

Volltextzugriff (PDF)

Burden of pulmonary arterial hypertension in Germany

Respiratory medicine, 2010-06, Vol.104 (6), p.902-910

2010

Volltextzugriff (PDF)

Which Adverse Effects Influence the Dropout Rate in Selective Serotonin Reuptake Inhibitor (Ssri) Treatment?

Value in health, 2014-11, Vol.17 (7), p.A460-A460

2014

Volltextzugriff (PDF)

Treatment Discontinuation In Patients With Urinary Incontinence Suffering From Glaucoma

Value in health, 2014-11, Vol.17 (7), p.A471-A471

2014

Volltextzugriff (PDF)

The Disease Burden of Influenza in Germany

Value in health, 2013-11, Vol.16 (7), p.A365-A365

2013

Volltextzugriff (PDF)

Cost of Influenza in Germany

Value in health, 2013-11, Vol.16 (7), p.A348-A348

2013

Volltextzugriff (PDF)

Economic evaluation of maintenance treatment with tacrolimus 01% ointment in adults with moderate to severe atopic dermatitis

British journal of dermatology (1951), 2008-12, Vol.159 (6), p.1322-1330

2008

Volltextzugriff (PDF)

Burden of Actinic Keratosis in Germany-Results of a Literature Research

Value in health, 2013-11, Vol.16 (7), p.A503-A503

2013

Volltextzugriff (PDF)

Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients

Value in health, 2014-11, Vol.17 (7), p.A663-A663

2014

Volltextzugriff (PDF)

PND26 Treatment Patterns and Resource Consumption in Patients With Multiple Sclerosis (MS)-Related Spasticity in Germany - Results of Move 1 Study

Value in health, 2012-11, Vol.15 (7), p.A550-A550

2012

Volltextzugriff (PDF)

PDB12 - Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

Value in health, 2016-11, Vol.19 (7), p.A666-A667

2016

Volltextzugriff (PDF)

Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

Value in health, 2016-11, Vol.19 (7), p.A666-A667

2016

Volltextzugriff (PDF)

Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals

Mycoses, 2012-11, Vol.55 (6), p.514-520

2012

Volltextzugriff (PDF)

Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD. A cost-effectiveness analysis for Germany

Deutsche medizinische Wochenschrift (1946), 2013-01, Vol.138 (4), p.119

2013

Volltextzugriff (PDF)

PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients

Value in health, 2011, Vol.14 (7), p.A385-A385

2011

Volltextzugriff (PDF)

Methodological Challenges in Comparing Topical Therapies in Dermatology in the Absence of Head to Head Studies

Value in health, 2013-11, Vol.16 (7), p.A608-A608

2013

Volltextzugriff (PDF)

PUK23 Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis

Value in health, 2012-11, Vol.15 (7), p.A459-A459

2012

Volltextzugriff (PDF)

PCV62 PERSISTENCE AND COMPLIANCE IN HYPERTENSION TREATMENT WITH OLMESARTAN MEDOXOMIL – ANALYSIS OF REAL-LIFE PRESCRIPTION DATA

Value in health, 2011, Vol.14 (3), p.A43-A43, Article A43

2011

Volltextzugriff (PDF)

PCV59 PERSISTENCE AND COMPLIANCE IN HYPERTENSIVE PATIENTS TREATED WITH FIXED OR UNFIXED COMBINATIONS OF ANGIOTENSIN RECEPTOR BLOCKERS, AMPLODIPINE AND HYDROCHLOROTHIAZIDE

Value in health, 2011, Vol.14 (3), p.A43-A43

2011

Volltextzugriff (PDF)

Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany

Journal of medical economics, 2012, Vol.15 (1), p.155-165

2012

Volltextzugriff (PDF)

PCV104 Persistence in Hypertension Treatment with Olmesartan Medoxomil Versus Valsartan - Analysis of Real-Life Prescription Data in Germany

Value in health, 2011, Vol.14 (7), p.A383-A383, Article A383

2011

Volltextzugriff (PDF)

Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

Value in health, 2016-11, Vol.19 (7), p.A524-A524

2016

Volltextzugriff (PDF)

PMH20 - Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

Value in health, 2016-11, Vol.19 (7), p.A524-A524

2016

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(89)
Tagungsberichte
(6)

Sprache

Englisch
(83)
Deutsch
(15)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study

Burden of pulmonary arterial hypertension in Germany

Which Adverse Effects Influence the Dropout Rate in Selective Serotonin Reuptake Inhibitor (Ssri) Treatment?

Treatment Discontinuation In Patients With Urinary Incontinence Suffering From Glaucoma

The Disease Burden of Influenza in Germany

Cost of Influenza in Germany

Economic evaluation of maintenance treatment with tacrolimus 01% ointment in adults with moderate to severe atopic dermatitis

Burden of Actinic Keratosis in Germany-Results of a Literature Research

Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients

PND26 Treatment Patterns and Resource Consumption in Patients With Multiple Sclerosis (MS)-Related Spasticity in Germany - Results of Move 1 Study

PDB12 - Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals

Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD. A cost-effectiveness analysis for Germany

PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients

Methodological Challenges in Comparing Topical Therapies in Dermatology in the Absence of Head to Head Studies

PUK23 Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis

PCV62 PERSISTENCE AND COMPLIANCE IN HYPERTENSION TREATMENT WITH OLMESARTAN MEDOXOMIL – ANALYSIS OF REAL-LIFE PRESCRIPTION DATA

PCV59 PERSISTENCE AND COMPLIANCE IN HYPERTENSIVE PATIENTS TREATED WITH FIXED OR UNFIXED COMBINATIONS OF ANGIOTENSIN RECEPTOR BLOCKERS, AMPLODIPINE AND HYDROCHLOROTHIAZIDE

Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany

PCV104 Persistence in Hypertension Treatment with Olmesartan Medoxomil Versus Valsartan - Analysis of Real-Life Prescription Data in Germany

Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

PMH20 - Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

Suchergebnisse filtern